Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market 2021 by Key Countries, Companies, Type and Application

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market 2021 by Key Countries, Companies, Type and Application

Report ID : 183862
Published On: Mar, 2021
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Gastroesophageal Reflux Disease (GERD) Drugs and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Medication

Minimally Invasive Surgery

Invasive Surgery

Market segment by Application, can be divided into

Heartburn

Acid reflux disorders

Market segment by players, this report covers

AstraZeneca, Plc.

Addex Therapeutics

Takeda Pharmaceutical Company Limited

Rottapharm (Meda AB)

Pfizer, Inc.

Eisai Co. Ltd.

The Procter & Gamble Company

Mederi Therapeutics

Aros Pharma

Torax Medical, Inc.

EndoGastric Solutions

Medigus Ltd.

Market segment by Region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, Spain, Benelux, Nordic, and Rest of Europe)

Asia (China, Japan, Korea, India, Southeast Asia, Australia, China Taiwan, and Rest of Asia)

South America (Brazil, Argentina, and Rest of South America)

MENA (Saudi Arabia, UAE, Turkey, and Rest of EMNA)

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices

1.2 Classification of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type

1.2.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type in 2020

1.2.3 Medication

1.2.4 Minimally Invasive Surgery

1.2.5 Invasive Surgery

1.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market by Application

1.3.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Heartburn

1.3.3 Acid reflux disorders

1.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size & Forecast

1.5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Region

1.5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region, (2016-2026)

1.5.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2016-2026)

1.5.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2016-2026)

1.5.5 Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2016-2026)

1.5.6 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2016-2026)

1.5.7 MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers

1.6.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints

1.6.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Trends Analysis

2 Company Profiles

2.1 AstraZeneca, Plc.

2.1.1 AstraZeneca, Plc. Details

2.1.2 AstraZeneca, Plc. Major Business

2.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AstraZeneca, Plc. Recent Developments and Future Plans

2.2 Addex Therapeutics

2.2.1 Addex Therapeutics Details

2.2.2 Addex Therapeutics Major Business

2.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Addex Therapeutics Recent Developments and Future Plans

2.3 Takeda Pharmaceutical Company Limited

2.3.1 Takeda Pharmaceutical Company Limited Details

2.3.2 Takeda Pharmaceutical Company Limited Major Business

2.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans

2.4 Rottapharm (Meda AB)

2.4.1 Rottapharm (Meda AB) Details

2.4.2 Rottapharm (Meda AB) Major Business

2.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Rottapharm (Meda AB) Recent Developments and Future Plans

2.5 Pfizer, Inc.

2.5.1 Pfizer, Inc. Details

2.5.2 Pfizer, Inc. Major Business

2.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Pfizer, Inc. Recent Developments and Future Plans

2.6 Eisai Co. Ltd.

2.6.1 Eisai Co. Ltd. Details

2.6.2 Eisai Co. Ltd. Major Business

2.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Eisai Co. Ltd. Recent Developments and Future Plans

2.7 The Procter & Gamble Company

2.7.1 The Procter & Gamble Company Details

2.7.2 The Procter & Gamble Company Major Business

2.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.7.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 The Procter & Gamble Company Recent Developments and Future Plans

2.8 Mederi Therapeutics

2.8.1 Mederi Therapeutics Details

2.8.2 Mederi Therapeutics Major Business

2.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mederi Therapeutics Recent Developments and Future Plans

2.9 Aros Pharma

2.9.1 Aros Pharma Details

2.9.2 Aros Pharma Major Business

2.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Aros Pharma Recent Developments and Future Plans

2.10 Torax Medical, Inc.

2.10.1 Torax Medical, Inc. Details

2.10.2 Torax Medical, Inc. Major Business

2.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Torax Medical, Inc. Recent Developments and Future Plans

2.11 BD

2.11.1 BD Details

2.11.2 BD Major Business

2.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 BD Recent Developments and Future Plans

2.12 EndoGastric Solutions

2.12.1 EndoGastric Solutions Details

2.12.2 EndoGastric Solutions Major Business

2.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 EndoGastric Solutions Recent Developments and Future Plans

2.13 Medigus Ltd.

2.13.1 Medigus Ltd. Details

2.13.2 Medigus Ltd. Major Business

2.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

2.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Medigus Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share

3.2.2 Top 10 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share

3.2.3 Market Competition Trend

3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue and Market Share by Type (2016-2021)

4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2016-2021)

5.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2021-2026)

6 North America

6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Country (2016-2026)

6.2 United States

6.2.1 United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (2016-2026)

6.2.2 United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

6.2.3 United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

6.3 Canada

6.3.1 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

6.3.2 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

6.3.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

6.4 Mexico

6.4.1 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

6.4.2 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

6.4.3 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7 Europe

7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Country (2016-2026)

7.2 Germany

7.2.1 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.2.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.2.3 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.3 France

7.3.1 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.3.2 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.3.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.4 UK

7.4.1 UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.4.2 UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.4.3 UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.5 Russia

7.5.1 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.5.2 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.5.3 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.6 Italy

7.6.1 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.6.2 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.6.3 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.7 Spain

7.7.1 Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.7.2 Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.7.3 Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.8 Benelux

7.8.1 Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.8.2 Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.8.3 Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

7.9 Nordic

7.9.1 Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

7.9.2 Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

7.9.3 Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8 Asia

8.1 Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Region (2016-2026)

8.2 China

8.2.1 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.2.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.2.3 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.3 Japan

8.3.1 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.3.2 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.3.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.4 South Korea

8.4.1 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.4.2 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.4.3 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.5 India

8.5.1 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.5.2 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.5.3 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.6 Southeast Asia

8.6.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.6.2 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.6.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.7 China Taiwan

8.7.1 China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.7.2 China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.7.3 China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

8.8 Australia

8.8.1 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

8.8.2 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

8.8.3 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

9 South America

9.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Country (2016-2026)

9.2 Brazil

9.2.1 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

9.2.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

9.2.3 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

9.3 Argentina

9.3.1 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

9.3.2 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

9.3.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

10 MENA

10.1 MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Region (2016-2026)

10.2 Saudi Arabia

10.2.1 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

10.2.2 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

10.2.3 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

10.3 UAE

10.3.1 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

10.3.2 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

10.3.3 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

10.4 Turkey

10.4.1 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2016-2026)

10.4.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2026)

10.4.3 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2021-2026)

Table 6. AstraZeneca, Plc. Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca, Plc. Major Business

Table 8. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 9. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Addex Therapeutics Corporate Information, Head Office, and Major Competitors

Table 11. Addex Therapeutics Major Business

Table 12. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 13. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors

Table 15. Takeda Pharmaceutical Company Limited Major Business

Table 16. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 17. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Rottapharm (Meda AB) Corporate Information, Head Office, and Major Competitors

Table 19. Rottapharm (Meda AB) Major Business

Table 20. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 21. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer, Inc. Major Business

Table 24. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 25. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Eisai Co. Ltd. Corporate Information, Head Office, and Major Competitors

Table 27. Eisai Co. Ltd. Major Business

Table 28. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 29. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. The Procter & Gamble Company Corporate Information, Head Office, and Major Competitors

Table 31. The Procter & Gamble Company Major Business

Table 32. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 33. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mederi Therapeutics Corporate Information, Head Office, and Major Competitors

Table 35. Mederi Therapeutics Major Business

Table 36. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 37. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Aros Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Aros Pharma Major Business

Table 40. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 41. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Torax Medical, Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Torax Medical, Inc. Major Business

Table 44. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 45. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. BD Corporate Information, Head Office, and Major Competitors

Table 47. BD Major Business

Table 48. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 49. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. EndoGastric Solutions Corporate Information, Head Office, and Major Competitors

Table 51. EndoGastric Solutions Major Business

Table 52. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 53. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Medigus Ltd. Corporate Information, Head Office, and Major Competitors

Table 55. Medigus Ltd. Major Business

Table 56. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions

Table 57. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Players (2019-2021)

Table 59. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players (2019-2021)

Table 60. Breakdown of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Head Office, Products and Services Provided

Table 62. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Mergers & Acquisitions in the Past Five Years

Table 63. Gastroesophageal Reflux Disease (GERD) Drugs and Devices New Entrants and Expansion Plans

Table 64. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Type (2016-2021)

Table 65. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Type (2016-2021)

Table 66. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Forecast by Type (2021-2026)

Table 67. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Application (2016-2021)

Table 68. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Forecast by Application (2021-2026)

Table 69. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Country (2016-2026)

Table 70. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Table 71. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 72. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 73. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 74. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 75. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 76. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 77. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 78. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 79. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 80. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 81. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 82. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 83. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Country (2016-2026)

Table 84. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Table 85. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 86. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 87. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 88. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 89. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 90. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 91. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 92. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 93. UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 94. UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 95. UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 96. UK Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 97. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 98. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 99. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 100. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 101. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 102. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 103. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 104. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 105. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 106. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 107. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 108. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 109. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 110. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 111. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 112. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 113. Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 114. Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 115. Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 116. Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 117. Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Region (2016-2026)

Table 118. Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2016-2026)

Table 119. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 120. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 121. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 122. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 123. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 124. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 125. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 126. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 127. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 128. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 129. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 130. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 131. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 132. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 133. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 134. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 135. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 136. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 137. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 138. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 139. China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 140. China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 141. China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 142. China Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 143. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 144. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 145. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 146. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 147. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Country (2016-2026)

Table 148. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Table 149. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 150. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 151. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 152. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 153. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 154. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 155. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 156. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 157. MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Country (2016-2026)

Table 158. MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Table 159. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 160. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type (2016-2026)

Table 161. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 162. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 163. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 164. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 165. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 166. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

Table 167. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Prospects (USD Million) by Type (2016-2026)

Table 168. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Percentage Share Breakdown by Type (2016-2026)

Table 169. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 170. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Analysis by Application (2016-2026)

List of Figures

Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Picture

Figure 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type in 2020

Figure 3. Medication

Figure 4. Minimally Invasive Surgery

Figure 5. Invasive Surgery

Figure 6. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application in 2020

Figure 7. Heartburn Picture

Figure 8. Acid reflux disorders Picture

Figure 9. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue and Outlook (2016-2026) & (USD Million)

Figure 11. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2016-2026)

Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region in 2020

Figure 13. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers

Figure 19. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints

Figure 20. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends

Figure 21. AstraZeneca, Plc. Recent Developments and Future Plans

Figure 22. Addex Therapeutics Recent Developments and Future Plans

Figure 23. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans

Figure 24. Rottapharm (Meda AB) Recent Developments and Future Plans

Figure 25. Pfizer, Inc. Recent Developments and Future Plans

Figure 26. Eisai Co. Ltd. Recent Developments and Future Plans

Figure 27. The Procter & Gamble Company Recent Developments and Future Plans

Figure 28. Mederi Therapeutics Recent Developments and Future Plans

Figure 29. Aros Pharma Recent Developments and Future Plans

Figure 30. Torax Medical, Inc. Recent Developments and Future Plans

Figure 31. BD Recent Developments and Future Plans

Figure 32. EndoGastric Solutions Recent Developments and Future Plans

Figure 33. Medigus Ltd. Recent Developments and Future Plans

Figure 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players in 2020

Figure 35. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 5 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share in 2020

Figure 37. Global Top 10 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Type in 2020

Figure 40. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2021-2026)

Figure 41. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Application (2016-2021)

Figure 42. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Application in 2020

Figure 43. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2021-2026)

Figure 44. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Figure 45. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) and Forecast (2016-2026)

Figure 46. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 47. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in Mexico: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 48. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Figure 49. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country in 2020

Figure 50. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 51. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 52. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in UK: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 53. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 54. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 55. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in Spain: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 56. Benelux Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 57. Nordic Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 58. Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Region (2016-2026)

Figure 59. Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Regions in 2020

Figure 60. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 61. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 62. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in South Korea: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 63. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 64. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 65. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in China Taiwan: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 66. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in Australia: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 67. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Figure 68. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country in 2020

Figure 69. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 70. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 71. MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2016-2026)

Figure 72. MENA Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Country in 2020

Figure 73. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 74. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 75. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market in Turkey: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 76. Methodology

Figure 77. Research Process and Data Source